Quality key factors
Factor
Value
Sales Growth (5y)
11.20%
EBIT Growth (5y)
12.37%
EBIT to Interest (avg)
2.87
Debt to EBITDA (avg)
3.27
Net Debt to Equity (avg)
1.01
Sales to Capital Employed (avg)
0.86
Tax Ratio
21.03%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.84%
ROE (avg)
11.31%
Valuation Key Factors 
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
4.46
EV to EBITDA
3.30
EV to Capital Employed
0.50
EV to Sales
0.51
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
11.24%
ROE (Latest)
11.23%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
Technical Movement
4What is working for the Company
OPERATING PROFIT MARGIN(Q)
Highest at 17.35 %
RAW MATERIAL COST(Y)
Fallen by -5.41% (YoY
NET PROFIT(Q)
Highest at VND 13,500.76 MM
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Agimexpharm Pharmaceutical JSC
Operating Profit Margin
Highest at 17.35 % and Grown
In each period in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Net Profit
Highest at VND 13,500.76 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (VND MM)
Raw Material Cost
Fallen by -5.41% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales






